Similar articles

• Dose of contrast material in the MR imaging evaluation of central nervous system tumors.

  Yuh WT, Halloran JI, Mayr NA, Fisher DJ, Nguyen HD, Simonson TM. Yuh WT, et al. J Magn Reson Imaging. 1994 May-Jun;4(3):243-9. doi: 10.1002/jmri.1880040304. J Magn Reson Imaging. 1994. PMID: 8061421 No abstract available.
• Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.

  Rippe DJ, Boyko OB, Fuller GN, Friedman HS, Oakes WJ, Schold SC. Rippe DJ, et al. AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):800-1. AJNR Am J Neuroradiol. 1990. PMID: 2114771 Free PMC article. No abstract available.
• Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.

  Mihara F, Gupta KL, Righi AM. Mihara F, et al. Radiat Med. 1994 Sep-Oct;12(5):209-12. Radiat Med. 1994. PMID: 7863024
• Use of MR imaging contrast agents in the brain.

  Bradley WG Jr, Yuh WT, Bydder GM. Bradley WG Jr, et al. J Magn Reson Imaging. 1993 Jan-Feb;3(1):199-218. doi: 10.1002/jmri.1880030133. J Magn Reson Imaging. 1993. PMID: 8428088 Review. No abstract available.
• Radiologic-pathologic correlation: meningioma of the optic nerve sheath.

  Ortiz O, Schochet SS, Kotzan JM, Kostick D. Ortiz O, et al. AJNR Am J Neuroradiol. 1996 May;17(5):901-6. AJNR Am J Neuroradiol. 1996. PMID: 8733965 Free PMC article. Review. No abstract available.